Advanced search×

Risk factors associated with severity and location of intracranial arterial stenosis.

Tanya N TN Turan, Achraf A AA Makki, Samuel S Tsappidi, George G Cotsonis, Michael J MJ Lynn, Harry J HJ Cloft, Marc I MI Chimowitz, and

Stroke 41(8):1636-40 (2010) PMID 20616323 PMCID PMC2927377

We sought to determine the vascular risk factors and demographic features associated with the severity and location of intracranial stenosis.

DOI: 10.1161/STROKEAHA.110.584672
Version: za2963e q8za1 q8zb7 q8zc3 q8zde q8zed q8zfa q8zgd
View PDF

Similar articles you may find interesting…

  1. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second Nationa...
    M B MB Bracken, M J MJ Shepard, ... J J Maroon

    N Engl J Med 322(20):1405-11 (1990) PMID 2278545

    We evaluated the efficacy and safety of methylprednisolone and naloxone in a multicenter randomized, double-blind, placebo-controlled trial in patients with acute spinal-cord injury, 95 percent of whom were treated within 14 hours of injury. Methylprednisolone was given to 162 patients as a bolus of...
  2. Treatment of acute spinal cord injury with methylprednisolone: results of a multicenter, randomized clinical trial.
    M B MB Bracken

    J Neurotrauma (1991) PMID 1920461

    Although some evidence of neurological improvement with naloxone exists in this trial, the improvement was never significantly better than that seen for placebo. Methylprednisolone (MP) was effective in reducing some of the permanent paralysis after acute spinal cord injury at the doses studied, but...
  3. CRASH (Corticosteroid Randomization after Significant Head Injury Trial): landmark and storm warning.
    Michael B MB Bracken

    Neurosurgery 57(6):1300-2; discussion 1300-2 (2005) PMID 16331179